Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tauns LaboratoriesTSE:197A -0.82%14 FCF Yield % is 3.30 as of Jul. 18, 2026. GuruFocus rates TSE:197A with a GF Score™ of 14/100. The stock has 6 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Tauns Laboratories ranks better than 71.81% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Tauns Laboratories's FCF Yield % or its related term are showing as below:
TSE:197A'
s FCF Yield % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 3.3
Current: 3.3
During the past 4 years, the highest FCF Yield % of Tauns Laboratories was 3.30%. The lowest was 0.00%. And the median was 0.00%.
TSE:197A's FCF Yield % is ranked better than 71.81% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.4
vs TSE:197A: 3.30
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Tauns Laboratories FCF Yield % Related Terms
Tauns Laboratories FCF Yield % Historical Data
* Premium members only.
The historical data trend for Tauns Laboratories's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:197A vs ISRG, BDX, MDLN: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Tauns Laboratories's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tauns Laboratories FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tauns Laboratories's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Tauns Laboratories's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tauns Laboratories (TSE:197A) has a FCF Yield % of 3.30 as of Jul. 18, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Tauns Laboratories and its competitors. According to the industry distribution chart, Tauns Laboratories ranks #241 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 28.2%.
Is Tauns Laboratories' FCF Yield % too high?
Tauns Laboratories' current FCF Yield % is 3.30. Based on the distribution chart, Tauns Laboratories ranks #241 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Tauns Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Tauns Laboratories' FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tauns Laboratories ranks #241 out of 855 companies for FCF Yield %. This puts Tauns Laboratories in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Tauns Laboratories and its competitors. Tauns Laboratories's current FCF Yield % is 3.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tauns Laboratories stock overvalued right now?
Tauns Laboratories (TSE:197A) has a current FCF Yield % of 3.30. The current FCF Yield % is 3.30. Tauns Laboratories' overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Tauns Laboratories (TSE:197A), the current FCF Yield % is 3.30 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
14GF Score
Get the complete analysis for TSE:197A
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:197A has been successfully added to your 
